Hayat Pharmaceutical Industries Co. PLC (ASE:HPIC)
Jordan · Delayed Price · Currency is JOD 2.920
+0.020 (0.69%)
At close: Aug 5, 2025
ASE:HPIC Income Statement
Financials in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 16.21 | 16.71 | 15.81 | 17.11 | 16.58 | 16.58 | Upgrade | |
Revenue Growth (YoY) | -1.28% | 5.72% | -7.61% | 3.15% | 0.02% | 5.99% | Upgrade |
Cost of Revenue | 7.16 | 7.45 | 5.93 | 6.01 | 5.39 | 5.2 | Upgrade |
Gross Profit | 9.04 | 9.26 | 9.88 | 11.09 | 11.19 | 11.38 | Upgrade |
Selling, General & Admin | 4.76 | 5.22 | 6.36 | 6.45 | 6.21 | 6.7 | Upgrade |
Research & Development | 0.76 | 0.7 | 0.66 | 0.58 | 0.47 | 0.35 | Upgrade |
Other Operating Expenses | -0.1 | -0.35 | 0.02 | -0.14 | -0.05 | -0.05 | Upgrade |
Operating Expenses | 5.42 | 5.57 | 7.04 | 6.89 | 6.77 | 7.2 | Upgrade |
Operating Income | 3.62 | 3.69 | 2.84 | 4.2 | 4.42 | 4.19 | Upgrade |
Interest Expense | -0.15 | -0.15 | -0.1 | -0.07 | -0.09 | -0.11 | Upgrade |
EBT Excluding Unusual Items | 3.47 | 3.54 | 2.74 | 4.14 | 4.33 | 4.08 | Upgrade |
Pretax Income | 3.47 | 3.54 | 2.74 | 4.14 | 4.33 | 4.08 | Upgrade |
Income Tax Expense | 0.47 | 0.45 | 0.41 | 0.61 | 0.69 | 0.57 | Upgrade |
Net Income | 3.01 | 3.09 | 2.33 | 3.53 | 3.64 | 3.51 | Upgrade |
Net Income to Common | 3.01 | 3.09 | 2.33 | 3.53 | 3.64 | 3.51 | Upgrade |
Net Income Growth | 2.09% | 32.73% | -34.04% | -3.12% | 3.75% | 5.36% | Upgrade |
Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | 10 | Upgrade |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | 10 | Upgrade |
EPS (Basic) | 0.31 | 0.33 | 0.25 | 0.37 | 0.38 | 0.37 | Upgrade |
EPS (Diluted) | 0.31 | 0.33 | 0.25 | 0.37 | 0.38 | 0.37 | Upgrade |
EPS Growth | 2.09% | 32.73% | -34.04% | -3.12% | 3.75% | 5.36% | Upgrade |
Free Cash Flow | 3.37 | 1.59 | 2.44 | 2.23 | 3.95 | 3.05 | Upgrade |
Free Cash Flow Per Share | 0.35 | 0.17 | 0.26 | 0.23 | 0.42 | 0.32 | Upgrade |
Dividend Per Share | 0.220 | 0.220 | 0.165 | 0.250 | 0.250 | 0.200 | Upgrade |
Dividend Growth | 33.33% | 33.33% | -34.00% | - | 25.00% | 100.00% | Upgrade |
Gross Margin | 55.80% | 55.40% | 62.51% | 64.85% | 67.48% | 68.65% | Upgrade |
Operating Margin | 22.35% | 22.09% | 17.96% | 24.58% | 26.66% | 25.25% | Upgrade |
Profit Margin | 18.55% | 18.49% | 14.73% | 20.63% | 21.96% | 21.17% | Upgrade |
Free Cash Flow Margin | 20.79% | 9.50% | 15.45% | 13.07% | 23.80% | 18.39% | Upgrade |
EBITDA | 4.77 | 4.79 | 3.93 | 5.26 | 5.32 | 4.67 | Upgrade |
EBITDA Margin | 29.43% | 28.70% | 24.84% | 30.73% | 32.09% | 28.14% | Upgrade |
D&A For EBITDA | 1.15 | 1.1 | 1.09 | 1.05 | 0.9 | 0.48 | Upgrade |
EBIT | 3.62 | 3.69 | 2.84 | 4.2 | 4.42 | 4.19 | Upgrade |
EBIT Margin | 22.35% | 22.09% | 17.96% | 24.58% | 26.66% | 25.25% | Upgrade |
Effective Tax Rate | 13.41% | 12.67% | 15.07% | 14.68% | 15.91% | 13.96% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.